©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6322-6334
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6322
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6322
Table 2 Diagnostic and therapeutic management of gastroesophageal reflux disease in adult patients with cystic fibrosis
| Adult patients | |
| Typical symptoms | Heartburn, regurgitation |
| Diagnostic tests indications | |
| PPIs Trial | Classical symptoms |
| Barium Swallow | Not for GERD diagnosis |
| Endoscopy | In presence of alarm symptoms |
| Esophageal biopsy | Exclude non-GERD diagnosis |
| Esophageal manometry | |
| Therapy | PPI for eight weeks |
| Additional options | Lifestyle modifications |
| Alginate or antiacide for symptoms relief | |
| Complications associated to therapy | Clostridium difficile infection |
| Risk of community-acquired pneumonia | |
| with a short-term PPI | |
- Citation: Bongiovanni A, Manti S, Parisi GF, Papale M, Mulè E, Rotolo N, Leonardi S. Focus on gastroesophageal reflux disease in patients with cystic fibrosis. World J Gastroenterol 2020; 26(41): 6322-6334
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6322